{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:00:52Z","timestamp":1793714452397,"version":"4.6.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["smrv-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine Reviews"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.smrv.2014.06.001","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T02:00:33Z","timestamp":1403143233000},"page":"75-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"special_numbering":"C","title":["Doxepin for insomnia: A systematic review of randomized placebo-controlled trials"],"prefix":"10.1016","volume":"19","author":[{"given":"Wing-Fai","family":"Yeung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-Fai","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kam-Ping","family":"Yung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommy Ho-Yee","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smrv.2014.06.001_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/smrv.2002.0186","article-title":"Epidemiology of insomnia: what we know and what we still need to learn","volume":"6","author":"Ohayon","year":"2002","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.smrv.2014.06.001_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5664\/jcsm.27286","article-title":"Clinical guideline for the evaluation and management of chronic insomnia in adults","volume":"4","author":"Rodin","year":"2008","journal-title":"J\u00a0Clin Sleep Med"},{"key":"10.1016\/j.smrv.2014.06.001_bib3","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1177\/0269881110379307","article-title":"British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders","volume":"24","author":"Wilson","year":"2010","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.smrv.2014.06.001_bib4","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/sleep\/27.8.1441","article-title":"Drugs used to treat insomnia in 2002: regulatory-based rather than evidence-based medicine","volume":"27","author":"Walsh","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2014.06.001_bib5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s11920-012-0302-y","article-title":"What is the role of sedating antidepressants, antipsychotics, and anticonvulsants in the management of insomnia?","volume":"14","author":"McCall","year":"2012","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.smrv.2014.06.001_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1744-6163.2009.00221.x","article-title":"Antidepressants and sleep: a review","volume":"45","author":"Holshoe","year":"2009","journal-title":"Perspect Psychiatr Care"},{"key":"10.1016\/j.smrv.2014.06.001_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-0447.2000.tb10944.x","article-title":"Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors","volume":"403","author":"Peretti","year":"2000","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.smrv.2014.06.001_bib8","series-title":"FDA approved drug products","author":"Food and Drug Administration","year":"2013"},{"key":"10.1016\/j.smrv.2014.06.001_bib9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2165\/11200810-000000000-00000","article-title":"Low-dose doxepin: in the treatment of insomnia","volume":"24","author":"Weber","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.smrv.2014.06.001_bib10","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.ncl.2005.05.002","article-title":"Pharmacologic and nonpharmacologic treatments of insomnia","volume":"23","author":"Becker","year":"2005","journal-title":"Neurol Clin"},{"key":"10.1016\/j.smrv.2014.06.001_bib11","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.smrv.2014.06.001_bib12","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2008"},{"key":"10.1016\/j.smrv.2014.06.001_bib13","series-title":"Drug approval package (application no.: 022036)","author":"Food and Drug Administration","year":"2010"},{"key":"10.1016\/j.smrv.2014.06.001_bib14","series-title":"Safety and efficacy of ramelteon and doxepin in subjects with chronic insomnia","author":"NCT00755495","year":"2012"},{"key":"10.1016\/j.smrv.2014.06.001_bib15","series-title":"Phase 2, double-blind, randomized, placebo-controlled, parallel-group, multicenter proof-of-concept study to evaluate the safety and efficacy of ramelteon taken in combination with doxepin for the treatment of subjects with chronic insomnia","author":"Takeda","year":"2008"},{"key":"10.1016\/j.smrv.2014.06.001_bib16","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1093\/sleep\/33.11.1553","article-title":"Efficacy and safety of doxepin 1 mg and 3 mg in a 12-week sleep laboratory and outpatient trial of elderly subjects with chronic primary insomnia","volume":"33","author":"Krystal","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2014.06.001_bib17","first-page":"1433","article-title":"Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia","volume":"34","author":"Krystal","year":"2011","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2014.06.001_bib18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.sleep.2011.09.006","article-title":"Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia","volume":"13","author":"Lankford","year":"2012","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2014.06.001_bib19","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/sleep\/30.11.1555","article-title":"Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia","volume":"30","author":"Roth","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2014.06.001_bib20","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.sleep.2010.07.006","article-title":"Efficacy and safety of doxepin 6 mg in a model of transient insomnia","volume":"11","author":"Roth","year":"2010","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2014.06.001_bib21","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.4088\/JCP.v69n1005","article-title":"Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study","volume":"69","author":"Scharf","year":"2008","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.smrv.2014.06.001_bib22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archpsyc.1974.01760160061013","article-title":"Doxepin in a single bedtime dose in psychoneurotic outpatients","volume":"31","author":"Goldberg","year":"1974","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.smrv.2014.06.001_bib23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4088\/JCP.v62n0609","article-title":"Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study","volume":"62","author":"Hajak","year":"2001","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.smrv.2014.06.001_bib24","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.smrv.2014.06.001_bib25","series-title":"The international classification of sleep disorders","author":"American Sleep Disorders Association","year":"1994"},{"key":"10.1016\/j.smrv.2014.06.001_bib26","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.injury.2008.02.013","article-title":"Industry-sponsored research","volume":"39","author":"Okike","year":"2008","journal-title":"Injury"},{"key":"10.1016\/j.smrv.2014.06.001_bib27","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s11606-007-0251-z","article-title":"The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs","volume":"22","author":"Buscemi","year":"2007","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.smrv.2014.06.001_bib28","doi-asserted-by":"crossref","first-page":"e8343","DOI":"10.1136\/bmj.e8343","article-title":"Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration","volume":"345","author":"Huedo-Medina","year":"2012","journal-title":"BMJ"}],"container-title":["Sleep Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079214000653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079214000653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T04:02:29Z","timestamp":1597982549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1087079214000653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":28,"alternative-id":["S1087079214000653"],"URL":"https:\/\/doi.org\/10.1016\/j.smrv.2014.06.001","relation":{},"ISSN":["1087-0792"],"issn-type":[{"value":"1087-0792","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Doxepin for insomnia: A systematic review of randomized placebo-controlled trials","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smrv.2014.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}